Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Cloning of S4D-SRCRB, a new soluble member of the group B scavenger receptor cysteine-rich family (SRCR-SF) mapping to human chromosome 7q11.23.

Padilla O, Pujana MA, López-de la Iglesia A, Gimferrer I, Arman M, Vilà JM, Places L, Vives J, Estivill X, Lozano F.

Immunogenetics. 2002 Dec;54(9):621-34. Epub 2002 Nov 6.

PMID:
12466895
2.

Genomic instability at the human CD5 gene promoter.

López-de la Iglesia A, Calvo J, Sanz-Vaqué L, Colomer D, Places L, García-Foncillas J, Campo E, Vives J, Lozano F.

Haematologica. 2002 Mar;87(3):235-41.

3.

High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome.

Ramos-Casals M, Font J, García-Carrasco M, Calvo J, Places L, Padilla O, Cervera R, Bowen MA, Lozano F, Ingelmo M.

Rheumatology (Oxford). 2001 Sep;40(9):1056-9.

PMID:
11561119
4.

Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases.

Vilà JM, Gimferrer I, Padilla O, Arman M, Places L, Simarro M, Vives J, Lozano F.

Eur J Immunol. 2001 Apr;31(4):1191-8.

5.

Identification of a novel single-nucleotide polymorphism (Val554Ile) and definition of eight common alleles for human IL4RA exon 11.

Lozano F, Places L, Vilà JM, Padilla O, Arman M, Gimferrer I, Suárez B, López de la Iglesia A, Miserachs N, Vives J.

Tissue Antigens. 2001 Mar;57(3):216-20.

PMID:
11285129
6.

Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling.

Vilà JM, Calvo J, Places L, Padilla O, Arman M, Gimferrer I, Aussel C, Vives J, Lozano F.

J Immunol. 2001 Jan 1;166(1):396-402.

7.

Genomic organization of the human CD5 gene.

Padilla O, Calvo J, Vilà JM, Arman M, Gimferrer I, Places L, Arias MT, Pujana MA, Vives J, Lozano F.

Immunogenetics. 2000 Oct;51(12):993-1001.

PMID:
11061284
8.

Identification of a novel HLA-Cw*07 variant (Cw*0714) in a German Caucasian family.

Lozano F, Arias MT, Vilà JM, Gimferrer I, Places L, Hummler A, Ehninger G, Martorell J, Vives J.

Tissue Antigens. 2000 Jan;55(1):86-8.

PMID:
10703619
9.

Identification of a natural soluble form of human CD5.

Calvo J, Places L, Espinosa G, Padilla O, Vilà JM, Villamor N, Ingelmo M, Gallart T, Vives J, Font J, Lozano F.

Tissue Antigens. 1999 Aug;54(2):128-37.

PMID:
10488739
10.

Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co-mitogenic signalling.

Calvo J, Padilla O, Places L, Vigorito E, Vilà JM, Vilella R, Milà J, Vives J, Bowen MA, Lozano F.

Tissue Antigens. 1999 Jul;54(1):16-26.

PMID:
10458319
11.

Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.

Calvo J, Places L, Padilla O, Vilà JM, Vives J, Bowen MA, Lozano F.

Eur J Immunol. 1999 Jul;29(7):2119-29.

12.

Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase.

Simarro M, Calvo J, Vilà JM, Places L, Padilla O, Alberola-Ila J, Vives J, Lozano F.

J Immunol. 1999 May 1;162(9):5149-55.

13.

Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II.

Calvo J, Vildà JM, Places L, Simarro M, Padilla O, Andreu D, Campbell KS, Aussel C, Lozano F.

J Immunol. 1998 Dec 1;161(11):6022-9.

14.

Isolation of two CD50 (ICAM-3)-negative Jurkat T-cell clones and their application for analysis of CD50 function.

Vilardell C, Juan M, Miralles A, Barceló JJ, Esparza J, Palou E, Vilella R, Places L, Lozano F, Alberola-Ila J, Gayà A, Yagüe J.

Tissue Antigens. 1998 May;51(5):509-19.

PMID:
9672149
15.

The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and -independent diacylglycerol production.

Simarro M, Pelassy C, Calvo J, Places L, Aussel C, Lozano F.

J Immunol. 1997 Nov 1;159(9):4307-15.

PMID:
9379026
16.

Conservation of a polymorphic microsatellite at orthologous positions in the human and mouse CD5 gene promoter.

Calvo J, Maertzdorf J, Roca A, Simarro M, Places L, Lázaro C, Vives J, Lozano F.

Immunogenetics. 1997;45(3):233-4. No abstract available.

PMID:
8995194
17.

CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell line.

Juan M, Viñas O, Pino-Otín MR, Places L, Martínez-Cáceres E, Barceló JJ, Miralles A, Vilella R, de la Fuente MA, Vives J, et al.

J Exp Med. 1994 Jun 1;179(6):1747-56.

18.

Association of an activation inducible serine kinase activity with CD5.

Alberola-Ila J, Places L, Lozano F, Vives J.

J Immunol. 1993 Nov 1;151(9):4423-30.

PMID:
7691949
19.

Different mechanisms regulate the monoclonal antibody-induced modulation of CD2, CD3, and CD5 in human lymphocytes.

Alberola-Ila J, Places L, Fabregat V, Vives J, Lozano F.

Cell Immunol. 1993 Apr 1;147(2):247-55.

PMID:
7680961
20.

Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1).

Lozano F, Places L, Alberola-Ila J, Milá M, Villamor N, Barceló J, Fabregat V, Vives J.

Leuk Res. 1993 Jan;17(1):9-16.

PMID:
8429685
21.

Intracellular events involved in CD5-induced human T cell activation and proliferation.

Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F.

J Immunol. 1992 Mar 1;148(5):1287-93.

PMID:
1371522
22.

Effect of protein kinase C activators on the phosphorylation and the surface expression of the CDw50 leukocyte antigen.

Lozano F, Alberola-Ila J, Places L, Vives J.

Eur J Biochem. 1992 Jan 15;203(1-2):321-6.

23.

The protein kinase C-independent human B cell proliferation induced via surface immunoglobulins is unaffected by CD45 monoclonal antibodies.

Ingles-Esteve J, Lozano F, Plana M, Alberola-Ila J, Places L, Vives J.

Immunobiology. 1991 Mar;182(2):152-60.

PMID:
1832138
24.

Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.

Alberola-Ila J, Places L, de la Calle O, Romero M, Yagüe J, Gallart T, Vives J, Lozano F.

J Immunol. 1991 Feb 15;146(4):1085-92.

PMID:
1671400
25.

Involvement of the CDw50 molecule in allorecognition.

Vilella R, Mila J, Lozano F, Alberola-Ila J, Places L, Vives J.

Tissue Antigens. 1990 Nov;36(5):203-10.

PMID:
1710077
26.

Phosphorylation-mediated changes in the electrophoretic mobility of CD5 molecules.

Lozano F, Alberola-Ila J, Places L, Gallart T, Vives J.

Eur J Biochem. 1990 Oct 24;193(2):469-77.

27.

Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells.

Lozano F, Alberola-Ila J, Places L, Gallart T, Vives J.

Immunology. 1990 Aug;70(4):434-9.

28.

Biochemical and serological characterization of a public antigenic determinant present on HLA-B molecules.

Lozano F, Borche L, Places L, Alberola-Ila J, Gayá A, Vilella R, Vives J.

Tissue Antigens. 1990 Apr;35(4):193-5. No abstract available.

PMID:
1695395
29.

Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset.

Gayá A, Alsinet E, Martorell J, Places L, de la Calle O, Yagüe J, Vives J.

Int Immunol. 1990;2(7):685-9.

PMID:
2149066
30.

Heterogeneity in the electrophoretic mobility of CD5 molecules after phorbol ester stimulation.

Lozano F, Alberola-Ila J, Places L, Vives J.

Mol Immunol. 1989 Dec;26(12):1187-90.

PMID:
2633049
31.

Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules.

Lozano F, Santos-Aguado J, Borche L, Places L, Doménech N, Gayá A, Vilella R, Vives J.

Immunogenetics. 1989;30(1):50-3. No abstract available.

PMID:
2473030

Supplemental Content

Loading ...
Support Center